TY - JOUR
T1 - The Genetic Spectrum of Familial Hypertriglyceridemia in Oman
AU - Al-Waili, Khalid
AU - Al-Rasadi, Khalid
AU - Al-Bulushi, Muna
AU - Habais, Mohammed
AU - Al-Mujaini, Abdullah
AU - Al-Yaarubi, Saif
AU - Rimbert, Antoine
AU - Zadjali, Razan
AU - Khaniabadi, Pegah Moradi
AU - Al-Barwani, Hamida
AU - Hasary, Sana
AU - Al-Dahmani, Zayana M
AU - Al-Badi, Hala
AU - Al-Maawali, Almundher
AU - Zadjali, Fahad
N1 - Copyright © 2022 Al-Waili, Al-Rasadi, Al-Bulushi, Habais, Al-Mujaini, Al-Yaarubi, Rimbert, Zadjali, Khaniabadi, Al-Barwani, Hasary, Al-Dahmani, Al-Badi, Al-Maawali and Zadjali.
PY - 2022
Y1 - 2022
N2 - Familial hypertriglyceridemia (F-HTG) is an autosomal disorder that causes severe elevation of serum triglyceride levels. It is caused by genetic alterations in
LPL,
APOC2,
APOA5,
LMF1, and
GPIHBP1 genes. The mutation spectrum of F-HTG in Arabic populations is limited. Here, we report the genetic spectrum of six families of F-HTG of Arab ancestry in Oman. Methods: six Omani families affected with triglyceride levels >11.2 mmol/L were included in this study. Ampli-Seq sequencing of the selected gene panels was performed. Whole-exome sequencing and copy number variant analysis were also performed in cases with negative exome results. Three novel pathogenic missense variants in the
LPL gene were identified, p.M328T, p.H229L, and p.S286G, along with a novel splice variant c.1322+15T > G. The
LPL p.H229L variant existed in double heterozygous mutation with the
APOA5 gene p.V153M variant. One family had a homozygous mutation in the
LMF1 gene (c.G107A; p.G36D) and a heterozygous mutation in the
LPL gene (c.G106A; p.D36N). All affected subjects did not have a serum deficiency of LPL protein. Genetic analysis in one family did not show any pathogenic variants even after whole-exome sequencing. These novel
LPL and
APOA5 mutations are not reported in other ethnic groups. This suggests that patients with F-HTG in Oman have a founder effect and are genetically unique. This warrants further analysis of patients of F-HTG in the Middle East for preventative and counseling purposes to limit the spread of the disease in a population of high consanguinity.
AB - Familial hypertriglyceridemia (F-HTG) is an autosomal disorder that causes severe elevation of serum triglyceride levels. It is caused by genetic alterations in
LPL,
APOC2,
APOA5,
LMF1, and
GPIHBP1 genes. The mutation spectrum of F-HTG in Arabic populations is limited. Here, we report the genetic spectrum of six families of F-HTG of Arab ancestry in Oman. Methods: six Omani families affected with triglyceride levels >11.2 mmol/L were included in this study. Ampli-Seq sequencing of the selected gene panels was performed. Whole-exome sequencing and copy number variant analysis were also performed in cases with negative exome results. Three novel pathogenic missense variants in the
LPL gene were identified, p.M328T, p.H229L, and p.S286G, along with a novel splice variant c.1322+15T > G. The
LPL p.H229L variant existed in double heterozygous mutation with the
APOA5 gene p.V153M variant. One family had a homozygous mutation in the
LMF1 gene (c.G107A; p.G36D) and a heterozygous mutation in the
LPL gene (c.G106A; p.D36N). All affected subjects did not have a serum deficiency of LPL protein. Genetic analysis in one family did not show any pathogenic variants even after whole-exome sequencing. These novel
LPL and
APOA5 mutations are not reported in other ethnic groups. This suggests that patients with F-HTG in Oman have a founder effect and are genetically unique. This warrants further analysis of patients of F-HTG in the Middle East for preventative and counseling purposes to limit the spread of the disease in a population of high consanguinity.
U2 - 10.3389/fgene.2022.886182
DO - 10.3389/fgene.2022.886182
M3 - Article
C2 - 35669187
SN - 1664-8021
VL - 13
SP - 886182
JO - Frontiers in Genetics
JF - Frontiers in Genetics
ER -